Ravi Jhaveri

4.4k citations
126 papers · 2.1k indexed · h-index 27
Topics
Hepatitis C virus research (44 papers)Hepatitis B Virus Studies (32 papers)Liver Disease Diagnosis and Treatment (31 papers)

In The Last Decade

Ravi Jhaveri

115 papers receiving 2.1k citations

Peers

Ravi Jhaveri
Comparison fields: 5 of 123
  • Epidemiology 1.3k
  • Hepatology 1.0k
  • Infectious Diseases 362
  • Pediatrics, Perinatology and Child Health 233
  • Surgery 195
Replace Mei Chong with:
Mei Chong Canada
Jefferson M. Jones United States
Francesca Cainelli Italy
James Hunter United Kingdom
G Rondini Italy
Stanley A. Gall United States
Ashutosh Tamhane United States
Sridhar V. Basavaraju United States
Eugene S. Hurwitz United States
Bareng A. S. Nonyane United States
Ravi Jhaveri relative to Mei Chong Canada Mei Chong's profile →
Citations per field
00.5×3.3×
Mei Chong · 1×
Citations per year

Countries citing papers authored by Ravi Jhaveri

Since Specialization
Citations

This map shows the geographic impact of Ravi Jhaveri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Jhaveri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Jhaveri more than expected).

Fields of papers citing papers by Ravi Jhaveri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Jhaveri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Jhaveri. The network helps show where Ravi Jhaveri may publish in the future.

Co-authorship network of co-authors of Ravi Jhaveri

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Jhaveri. A scholar is included among the top collaborators of Ravi Jhaveri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Jhaveri. Ravi Jhaveri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 4
6 4
7 1
8 1
9 4
10 2
11 2
12 0
13 9
14 5
15 30
16 19
17 14
18 7
19 10
20 4

About Ravi Jhaveri

Ravi Jhaveri is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 126 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (32 papers) and Liver Disease Diagnosis and Treatment (31 papers). The work is most often cited by research in Hepatology (1.0k citations), Epidemiology (1.3k citations) and Infectious Diseases (362 citations). Ravi Jhaveri has collaborated with scholars based in United States, Egypt and Democratic Republic of the Congo. Frequent co-authors include Samer S. El‐Kamary, Anna Mae Diehl, John G. McHutchison, Geeta K. Swamy, Michelle Shardell, Mehreen Arshad, William C. Grant, Allison James, Teresa L. Kauf and A. Sidney Barritt. Their work appears in journals such as Nature Communications, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026